{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:27:53Z","timestamp":1775215673038,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00204-020-02684-8","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T17:04:06Z","timestamp":1582823046000},"page":"1215-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Determination of structural factors affecting binding to mu, kappa and delta opioid receptors"],"prefix":"10.1007","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-522X","authenticated-orcid":false,"given":"Svetoslav","family":"Slavov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Mattes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Beger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"2684_CR1","unstructured":"ACD\/NMR Predictor Release 12.00, version 12.5 (2011) Advanced Chemistry Development, Toronto, Canada"},{"key":"2684_CR2","unstructured":"ACD\/XNMR Suite Release 12.00, version 12.5 (2011) Advanced Chemistry Development, Toronto, Canada"},{"issue":"6","key":"2684_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/10673220490910844","volume":"12","author":"B Adinoff","year":"2004","unstructured":"Adinoff B (2004) Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 12(6):305\u2013320. https:\/\/doi.org\/10.1080\/10673220490910844","journal-title":"Harv Rev Psychiatry"},{"key":"2684_CR4","first-page":"36","volume-title":"Basic 1H-and 13C-NMR spectroscopy","author":"M Balci","year":"2005","unstructured":"Balci M (2005) Basic 1H-and 13C-NMR spectroscopy. Elsevier, Amsterdam, pp 36\u201375"},{"issue":"3","key":"2684_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0014-2999(87)90397-9","volume":"144","author":"PJ Birch","year":"1987","unstructured":"Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at \u03ba opioid receptors. Eur J Pharmacol 144(3):405\u2013408. https:\/\/doi.org\/10.1016\/0014-2999(87)90397-9","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"2684_CR6","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1021\/jf071031h","volume":"55","author":"J Caballero","year":"2007","unstructured":"Caballero J, Saavedra M, Fern\u00e1ndez M, Gonz\u00e1lez-Nilo FD (2007) Quantitative structure\u2013activity relationship of rubiscolin analogues as \u03b4 opioid peptides using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). J Agric Food Chem 55(20):8101\u20138104. https:\/\/doi.org\/10.1021\/jf071031h","journal-title":"J Agric Food Chem"},{"issue":"3","key":"2684_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.conb.2004.05.005","volume":"14","author":"C Contet","year":"2004","unstructured":"Contet C, Kieffer BL, Befort K (2004) Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14(3):370\u2013378. https:\/\/doi.org\/10.1016\/j.conb.2004.05.005","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"2684_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.2042-7158.1988.tb05274.x","volume":"40","author":"IM Coupar","year":"1988","unstructured":"Coupar IM, Quinn MJ (1988) The effects of the selective \u03ba-opioid agonist MR 2034 on the guinea-pig ileum. J Pharm Pharmacol 40(5):378\u2013380. https:\/\/doi.org\/10.1111\/j.2042-7158.1988.tb05274.x","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"2684_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","volume":"19","author":"E Darcq","year":"2018","unstructured":"Darcq E, Kieffer BL (2018) Opioid receptors: drivers to addiction? Nat Rev Neurosci 19(8):499. https:\/\/doi.org\/10.1038\/s41583-018-0028-x","journal-title":"Nat Rev Neurosci"},{"key":"2684_CR10","unstructured":"DEA-DCT-DIR-032-18; Drug Enforcement Administration-DCT-DIR-032-18"},{"issue":"2","key":"2684_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1527-3458.2005.tb00270.x","volume":"11","author":"J Dortch-Carnes","year":"2005","unstructured":"Dortch-Carnes J, Potter DE (2005) Bremazocine: a \u03ba-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev 11(2):195\u2013212. https:\/\/doi.org\/10.1111\/j.1527-3458.2005.tb00270.x","journal-title":"CNS Drug Rev"},{"key":"2684_CR12","unstructured":"DrugFacts: Understanding Drug Abuse and Addiction, National Institute on Drug Abuse (2012), https:\/\/www.drugabuse.gov\/publications\/drugfacts\/understanding-drug-abuse-addiction. Accessed 4 Nov 2019"},{"issue":"5","key":"2684_CR13","doi-asserted-by":"publisher","first-page":"e0197734","DOI":"10.1371\/journal.pone.0197734","volume":"13","author":"CR Ellis","year":"2018","unstructured":"Ellis CR, Kruhlak NL, Kim MT, Hawkins EG, Stavitskaya L (2018) Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PloS One 13(5):e0197734. https:\/\/doi.org\/10.1371\/journal.pone.0197734","journal-title":"PloS One"},{"issue":"2","key":"2684_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/qsar.19920110206","volume":"11","author":"GR Famini","year":"1992","unstructured":"Famini GR, Ashman WP, Mickiewicz AP, Wilson LY (1992) Using theoretical descriptors in quantitative structure\u2013activity relationships: opiate receptor activity by fentanyl-like compounds. Quant Struct Act Relat 11(2):162\u2013170. https:\/\/doi.org\/10.1002\/qsar.19920110206","journal-title":"Quant Struct Act Relat"},{"issue":"3","key":"2684_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1124\/pr.114.008979","volume":"68","author":"L Gendron","year":"2016","unstructured":"Gendron L, Cahill CM, von Zastrow M, Schiller PW, Pineyro G (2016) Molecular pharmacology of \u03b4-opioid receptors. Pharmacol Rev 68(3):631\u2013700. https:\/\/doi.org\/10.1124\/pr.114.008979","journal-title":"Pharmacol Rev"},{"issue":"4","key":"2684_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/YIC.0000000000000069","volume":"30","author":"M Grosshans","year":"2015","unstructured":"Grosshans M, Mutschler J, Kiefer F (2015) Treatment of cocaine craving with as-needed nalmefene, a partial \u03ba-opioid receptor agonist: first clinical experience. Int Clin Psychopharmacol 30(4):237\u2013238. https:\/\/doi.org\/10.1097\/YIC.0000000000000069","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"2684_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1021\/jm901503e","volume":"53","author":"LW Hsin","year":"2010","unstructured":"Hsin LW, Chang LT, Rothman RB, Dersch CM, Fishback JA, Matsumoto RR (2010) Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines. J Med Chem 53(3):1392\u20131396. https:\/\/doi.org\/10.1021\/jm901503e","journal-title":"J Med Chem"},{"key":"2684_CR18","unstructured":"HyperChem 8 Professional, version 8.03 (2007) HyperCube Inc., Gainesville, FL, USA"},{"key":"2684_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fpsyt.2013.00117","volume":"4","author":"JM Kennett","year":"2013","unstructured":"Kennett JM, Matthews S, Snoek A (2013) Pleasure and addiction. Front Psychiatry 4:117. https:\/\/doi.org\/10.3389\/fpsyt.2013.00117","journal-title":"Front Psychiatry"},{"issue":"9","key":"2684_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/0028-3908(82)90085-5","volume":"21","author":"JD Leander","year":"1982","unstructured":"Leander JD (1982) Effects of ketazocine, ethylketazocine and phenazocine on schedule-controlled behavior: antagonism by naloxone. Neuropharmacology 21(9):923\u2013928. https:\/\/doi.org\/10.1016\/0028-3908(82)90085-5","journal-title":"Neuropharmacology"},{"issue":"6","key":"2684_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00894-005-0084-9","volume":"12","author":"W Li","year":"2006","unstructured":"Li W, Tang Y, Xie Q, Sheng W, Qiu ZB (2006a) 3D\u2013QSAR studies of orvinol analogs as \u03ba-opioid agonists. J Mol Model 12(6):877\u2013884. https:\/\/doi.org\/10.1007\/s00894-005-0084-9","journal-title":"J Mol Model"},{"issue":"3","key":"2684_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.bmc.2005.08.052","volume":"14","author":"W Li","year":"2006","unstructured":"Li W, Tang Y, Zheng YL, Qiu ZB (2006b) Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists. Bioorg Med Chem 14(3):601\u2013610. https:\/\/doi.org\/10.1016\/j.bmc.2005.08.052","journal-title":"Bioorg Med Chem"},{"key":"2684_CR23","first-page":"186","volume-title":"Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens","author":"EJ Lien","year":"1978","unstructured":"Lien EJ, Tong GL, Srulevitch DB, Dias C (1978) QSAR of narcotic analgetic agents. In: Barnett G, Trsic M, Willette R (eds) Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens, vol 22. NIDA Research Monograph, Rockville, pp 186\u2013196"},{"issue":"23","key":"2684_CR24","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1016\/j.bmcl.2010.09.116","volume":"20","author":"M Liu","year":"2010","unstructured":"Liu M, He L, Hu X, Liu P, Luo HB (2010) 3D-QSAR, homology modeling, and molecular docking studies on spiropiperidines analogues as agonists of nociceptin\/orphanin FQ receptor. Bioorg Med Chem Lett 20(23):7004\u20137010. https:\/\/doi.org\/10.1016\/j.bmcl.2010.09.116","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"2684_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","volume":"36","author":"PE Lutz","year":"2013","unstructured":"Lutz PE, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends neurosci 36(3):195\u2013206. https:\/\/doi.org\/10.1016\/j.tins.2012.11.002","journal-title":"Trends neurosci"},{"key":"2684_CR26","unstructured":"MATLAB, version 8.0 (2012) The MathWorks Inc., Cambridge, MA"},{"issue":"1","key":"2684_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/bjaceaccp\/mki004","volume":"5","author":"J McDonald","year":"2005","unstructured":"McDonald J, Lambert DG (2005) Opioid receptors. Continuing education in anaesthesia. Crit Care Pain 5(1):22\u201325. https:\/\/doi.org\/10.1093\/bjaceaccp\/mki004","journal-title":"Crit Care Pain"},{"issue":"7","key":"2684_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jmgm.2009.12.008","volume":"28","author":"DL McGovern","year":"2010","unstructured":"McGovern DL, Mosier PD, Roth BL, Westkaemper RB (2010) CoMFA analyses of C-2 position Salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity. J Mol Graph Model 28(7):612\u2013625. https:\/\/doi.org\/10.1016\/j.jmgm.2009.12.008","journal-title":"J Mol Graph Model"},{"issue":"14","key":"2684_CR29","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1021\/jm00040a004","volume":"37","author":"A Naylor","year":"1994","unstructured":"Naylor A, Judd DB, Scopes DI, Hayes AG, Birch PJ (1994) 4-[(Alkylamino)methyl]furo[3,2-c]pyridines: a new series of selective kappa-receptor agonists. J Med Chem 37(14):2138\u20132144. https:\/\/doi.org\/10.1021\/jm00040a004","journal-title":"J Med Chem"},{"key":"2684_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/10629360802083848","volume":"19","author":"G Patlewicz","year":"2008","unstructured":"Patlewicz G, Jeliazkova N, Gallegos Saliner A, Worth AP (2008) Toxmatch\u2014a new software tool to aid in the development and evaluation of chemically similar groups. SAR QSAR Environ Res 19:397\u2013412. https:\/\/doi.org\/10.1080\/10629360802083848","journal-title":"SAR QSAR Environ Res"},{"issue":"5","key":"2684_CR31","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/jm049117e","volume":"48","author":"Y Peng","year":"2005","unstructured":"Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ (2005a) 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies. J Med Chem 48(5):1620\u20131629. https:\/\/doi.org\/10.1021\/jm049117e","journal-title":"J Med Chem"},{"issue":"1","key":"2684_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jmgm.2005.05.001","volume":"24","author":"Y Peng","year":"2005","unstructured":"Peng Y, Keenan SM, Zhang Q, Welsh WJ (2005b) 3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs. J Mol Graph Model 24(1):25\u201333. https:\/\/doi.org\/10.1016\/j.jmgm.2005.05.001","journal-title":"J Mol Graph Model"},{"issue":"21","key":"2684_CR33","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/jm000228x","volume":"43","author":"N Plobeck","year":"2000","unstructured":"Plobeck N, Delorme D, Wei ZY, Yang H, Zhou F, Schwarz P, Gawell L, Gagnon H, Pelcman B, Schmidt R, Yue SY (2000) New diarylmethylpiperazines as potent and selective nonpeptidic \u03b4 opioid receptor agonists with increased in vitro metabolic stability. J Med Chem 43(21):3878\u20133894. https:\/\/doi.org\/10.1021\/jm000228x","journal-title":"J Med Chem"},{"key":"2684_CR34","doi-asserted-by":"publisher","first-page":"B5","DOI":"10.1007\/978-3-662-22455-7","volume-title":"Tables of spectral data for structure determination of organic compounds","author":"E Pretsch","year":"1983","unstructured":"Pretsch E, Clerc T, Seibl J, Simon W (1983) Tables of spectral data for structure determination of organic compounds. Springer, Berlin, pp B5\u2013B10"},{"issue":"12","key":"2684_CR35","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0968-0896(97)00163-6","volume":"5","author":"SE Schullery","year":"1997","unstructured":"Schullery SE, Mohammedshah T, Makhlouf H, Marks EL, Wilenkin BS, Escobar S, Mousigian C, Heyl DL (1997) Binding to \u03b4 and \u03bc opioid receptors by deltorphin I\/II analogues modified at the Phe3 and Asp4\/Glu4 side chains: a report of 32 new analogues and a QSAR study. Bioorg Med Chem 5(12):2221\u20132234. https:\/\/doi.org\/10.1016\/S0968-0896(97)00163-6","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"2684_CR36","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1021\/jp202542g","volume":"115","author":"J Shim","year":"2011","unstructured":"Shim J, Coop A, MacKerell AD Jr (2011) Consensus 3D model of \u03bc-opioid receptor ligand efficacy based on a quantitative conformationally sampled pharmacophore. J Phys Chem B 115(22):7487\u20137496. https:\/\/doi.org\/10.1021\/jp202542g","journal-title":"J Phys Chem B"},{"issue":"1","key":"2684_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/npp.2008.165","volume":"34","author":"TS Shippenberg","year":"2009","unstructured":"Shippenberg TS (2009) The dynorphin\/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders? Neuropsychopharmacology 34(1):247. https:\/\/doi.org\/10.1038\/npp.2008.165","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"2684_CR38","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1007\/s00204-017-1995-9","volume":"91","author":"S Slavov","year":"2017","unstructured":"Slavov S, Stoyanova-Slavova I, Li S, Zhao J, Huang R, Xia M, Beger R (2017) Why are most phospholipidosis inducers also hERG blockers? Arch Toxicol 91(12):3885\u20133895. https:\/\/doi.org\/10.1007\/s00204-017-1995-9","journal-title":"Arch Toxicol"},{"issue":"3","key":"2684_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/etc.3578","volume":"36","author":"SH Slavov","year":"2017","unstructured":"Slavov SH, Beger RD (2017) Rigorous 3-dimensional spectral data activity relationship approach modeling strategy for ToxCast estrogen receptor data classification, validation, and feature extraction. Environ Toxicol Chem 36(3):823\u2013830. https:\/\/doi.org\/10.1002\/etc.3578","journal-title":"Environ Toxicol Chem"},{"issue":"1","key":"2684_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1758-2946-5-47","volume":"5","author":"SH Slavov","year":"2013","unstructured":"Slavov SH, Pearce BA, Buzatu DA, Wilkes JG, Beger RD (2013) Complementary PLS and KNN algorithms for improved 3D-QSDAR consensus modeling of AhR binding. J Cheminformatics 5(1):47. https:\/\/doi.org\/10.1186\/1758-2946-5-47","journal-title":"J Cheminformatics"},{"issue":"7","key":"2684_CR41","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00204-018-2216-x","volume":"92","author":"SH Slavov","year":"2018","unstructured":"Slavov SH, Stoyanova-Slavova I, Mattes W, Beger RD, Br\u00fcschweiler BJ (2018) Computational identification of structural factors affecting the mutagenic potential of aromatic amines: study design and experimental validation. Arch Toxicol 92(7):2369\u20132384. https:\/\/doi.org\/10.1007\/s00204-018-2216-x","journal-title":"Arch Toxicol"},{"issue":"23","key":"2684_CR42","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1016\/j.bmc.2014.08.021","volume":"22","author":"SH Slavov","year":"2014","unstructured":"Slavov SH, Wilkes JG, Buzatu DA, Kruhlak NL, Willard JM, Hanig JP, Beger RD (2014) Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprints. Bioorg Med Chem 22(23):6706\u20136714. https:\/\/doi.org\/10.1016\/j.bmc.2014.08.021","journal-title":"Bioorg Med Chem"},{"key":"2684_CR43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.36076\/ppj.2008\/11\/225","volume":"11","author":"II Standiford Helm","year":"2008","unstructured":"Standiford Helm II, Trescot AM, Colson J, Sehgal N, Silverman S (2008) Opioid antagonists, partial agonists, and agonists\/antagonists: the role of office-based detoxification. Pain Physician 11:225\u2013235","journal-title":"Pain Physician"},{"key":"2684_CR44","unstructured":"The Binding Database. https:\/\/bindingdb.org\/bind\/index.jsp. Accessed 5 Feb 2019"},{"issue":"2","key":"2684_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/pr.114.009209","volume":"68","author":"L Toll","year":"2016","unstructured":"Toll L, Bruchas MR, Cox BM, Zaveri NT (2016) Nociceptin\/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 68(2):419\u2013457. https:\/\/doi.org\/10.1124\/pr.114.009209","journal-title":"Pharmacol Rev"},{"issue":"6","key":"2684_CR46","first-page":"817","volume":"164","author":"DM Tomkins","year":"2001","unstructured":"Tomkins DM, Sellers EM (2001) Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. Can Med Assoc J 164(6):817\u2013821","journal-title":"Can Med Assoc J"},{"key":"2684_CR47","first-page":"176","volume-title":"Handbook of chemoinformatics algorithms","author":"A Tropsha","year":"2010","unstructured":"Tropsha A, Golbraikh A (2010) Predictive quantitative structure-activity modeling. Data preparation and the general modeling workflow. In: Faulon JL, Bender A (eds) Handbook of chemoinformatics algorithms. CRC Press, Boca Raton, pp 176\u2013177"},{"key":"2684_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ejmech.2018.02.046","volume":"148","author":"R Turnaturi","year":"2018","unstructured":"Turnaturi R, Marrazzo A, Parenti C, Pasquinucci L (2018) Benzomorphan scaffold for opioid analgesics and pharmacological tools development: a comprehensive review. Eur J Med Chem 148:410\u2013422. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.046","journal-title":"Eur J Med Chem"},{"issue":"13","key":"2684_CR49","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","volume":"43","author":"RJ Valentino","year":"2018","unstructured":"Valentino RJ, Volkow ND (2018) Untangling the complexity of opioid receptor function. Neuropsychopharmacology 43(13):2514\u20132520. https:\/\/doi.org\/10.1038\/s41386-018-0225-3","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2684_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejmech.2005.10.017","volume":"41","author":"XH Wang","year":"2006","unstructured":"Wang XH, Tang Y, Xie Q, Qiu ZB (2006) QSAR study of 4-phenylpiperidine derivatives as \u03bc opioid agonists by neural network method. Eur J Med Chem 41(2):226\u2013232. https:\/\/doi.org\/10.1016\/j.ejmech.2005.10.017","journal-title":"Eur J Med Chem"},{"issue":"21","key":"2684_CR51","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1021\/jm000229p","volume":"43","author":"ZY Wei","year":"2000","unstructured":"Wei ZY, Brown W, Takasaki B, Plobeck N, Delorme D, Zhou F, Yang H, Jones P, Gawell L, Gagnon H, Schmidt R (2000) N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl) benzamide: a novel, exceptionally selective, potent \u03b4 opioid receptor agonist with oral bioavailability and its analogues. J Med Chem 43(21):3895\u20133905. https:\/\/doi.org\/10.1021\/jm000229p","journal-title":"J Med Chem"},{"issue":"12","key":"2684_CR52","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1016\/j.bmc.2010.04.069","volume":"18","author":"N Yamaotsu","year":"2010","unstructured":"Yamaotsu N, Fujii H, Nagase H, Hirono S (2010) Identification of the three-dimensional pharmacophore of \u03ba-opioid receptor agonists. Bioorg Med Chem 18(12):4446\u20134452. https:\/\/doi.org\/10.1016\/j.bmc.2010.04.069","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"2684_CR53","first-page":"77","volume":"31","author":"TT Yang","year":"1981","unstructured":"Yang TT, Srulevitch DB, Lien EJ (1981) QSAR of synthetic narcotic analgetic agents related to fentanyl. Acta Pharm Jugosl 31(2):77\u201385","journal-title":"Acta Pharm Jugosl"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-020-02684-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T19:43:58Z","timestamp":1665949438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-020-02684-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02684-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}